Cite
Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia.
MLA
Shibusawa, Motoharu, et al. “Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia.” JAMA, vol. 326, no. 4, July 2021, p. 359. EBSCOhost, https://doi.org/10.1001/jama.2021.8151.
APA
Shibusawa, M., Kidoguchi, K., & Tanimoto, T. (2021). Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia. JAMA, 326(4), 359. https://doi.org/10.1001/jama.2021.8151
Chicago
Shibusawa, Motoharu, Keisuke Kidoguchi, and Tetsuya Tanimoto. 2021. “Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia.” JAMA 326 (4): 359. doi:10.1001/jama.2021.8151.